CJC-1295 with DAC is commonly referenced in preclinical research focused on growth hormone–releasing hormone signalling, endocrine pathways, receptor activity, and mechanisms involved in growth hormone regulation. The DAC modification provides a useful research model for investigating sustained signalling characteristics in controlled laboratory studies.
- Research value: supports research into GHRH signalling, growth hormone pathways, receptor activity, and endocrine response mechanisms.
- Research areas: growth hormone research, GHRH pathways, endocrine signalling, and receptor biology.
- Available sizes: 10MG
- Format: Lyophilized powder
- Specs: Purity: >=99% | Form: Lyophilized Powder | Storage: -20°C
For research purposes only. Not for human consumption.